Skip to main content
. 2024 Aug 5;15:1423200. doi: 10.3389/fpsyt.2024.1423200

Table 2.

Laboratory characteristics of MHD patients.

Variables Depression (n=80) Non-depression (n=126) P
WBC (×109/L) 6.63 (5.48, 7.52) 6.13 (5.27, 7.12) 0.058
HGB (g/L) 119 (109, 127) 116 (105.75, 123) 0.033
NEUT# (×109/L) 4.77 (3.96, 5.72) 4.06 (3.49, 5.09) 0.004
LYMPH# (×109/L) 1.04 (0.83, 1.32) 1.2 (0.92, 1.5) 0.017
MONO# (×109/L) 0.4 (0.35, 0.5) 0.4 (0.32, 0.5) 0.514
PLT (×109/L) 177 (155, 224.75) 176 (141, 218.25) 0.423
SII Median (Q1–Q3) 843.92 (595.08, 1173.43) 605.73 (428.78, 844.96) <0.0001
Scr (μmol/L) 913.31 ± 245.33 909.1 ± 254.21 0.906
BUN (mmol/L) 26.42 ± 6.65 27.55 ± 7.92 0.295
UA (μmol/L) 407.87 ± 96 421.36 ± 102.22 0.346
GLU (mmol/L) 7.66 (6.42, 11.5) 7.6 (6, 10.42) 0.433
ALP (U/L) 84 (65, 105.1) 86 (69.9, 115) 0.411
ALB (g/L) 39.6 (37.8, 42.1) 40 (37.35, 42.1) 0.954
PAB (mg/L) 318 (244, 383) 310 (247, 365.5) 0.585
TC (mmol/L) 3.47 (3.07, 4.22) 3.82 (3.08, 4.44) 0.133
TG (mmol/L) 1.91 (1.33, 3.14) 1.71 (1.04, 2.33) 0.031
Ca (mmol/L) 2.2 (2.09, 2.35) 2.22 (2.09, 2.35) 0.768
P (mmol/L) 1.88 ± 0.6 1.86 ± 0.54 0.824
Na (mmol/L) 138.5 (136.6, 139.7) 138.1 (135.8, 139.83) 0.363
CL (mmol/L) 100.35 ± 4.08 99.48 ± 3.91 0.127
K (mmol/L) 4.93 ± 0.66 5.11 ± 0.71 0.059
Mg (mmol/L) 1.06 ± 0.16 1.11 ± 0.18 0.048
CO2cp (mmol/L) 21.65 (20.2, 23.4) 21.9 (20, 23.7) 0.504
Fer (μg/L) 379.3 (234.38, 797.5) 330.3 (209.4, 687.76) 0.246
iPTH (pg/mL) 260.35 (147.3, 488.85) 268.3 (185.95, 438.75) 0.726

Values are presented as means ± SD or Median (Q1-Q3)/N (%)

WBC, white blood cells; HGB, hemoglobin; NEUT#, neutrophils; LYMPH#, lymphocytes; MONO#, monocytes; PLT, platelets; SII, systemic immune-inflammatory; Scr, serum creatinine; BUN, blood urea nitrogen; UA, uric acid; GLU, glucose; ALP, alkaline Phosphatase; ALB, albumin; PAB, prealbumin; TC, total cholesterol; TG, triglyceride; CO2cp, carbondioxide combining power; Fer, ferritin; iPTH, intact Parathyroid Hormone.